References
- Changeux J.-P. The acetylcholine receptor: an “allosteric” membrane protein. The Harvey Lectures 1981; 75: 85–254
- Nickerson M. Receptor occupancy and tissue response. Nature 1956; 178: 697–698
- Lindeberg G., Vilhardt H., Larsson L.-E., Melin P., Pliška V. Effect of O-alkylated analogues of lysine vasopressin on adenylate cyclase in pig kidney membranes. J. Receptor Res. 1980; 389–402
- Stephenson R. P. A modification of receptor theory. Brit. J. Pharmacol. 1956; 11: 379–393
- Ariëns E. J., van Rossum J. M., Simonis A. M. A theoretical basis of molecular pharmacology. Arzneim.-Forsch. 1956; 282–293
- Furchgott R. F. The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. Adv. Drug Res. 1966; 21–55
- Furchgott R. F., Bursztyn P. Comparison of dissociation constants and of relative efficacies of selected agonists acting on parasympathetic receptors. Ann. N.Y. Acad. Sci. 1967; 144: 882–899
- Atkins G. L. A simple digital-computer program for estimating the parameters of the Hill equation. Eur. J. Biochem. 1973; 33: 175–180
- Pliška V., Sachs H. The interaction of lysine vasopressin with free and agarose-bound neurophysin II: Two classes of binding sites. Eur. J. Biochem. 1974; 41: 229–239
- Wilkinson G. N. Statistical estimations in enzyme kinetics. Biochem. J. 1961; 80: 324–332
- Beveridge G. S.G., Schechter R. S. Optimalization: Theory and Practice. Mc Graw-Hill, New York 1970; 141–202
- Draper N. R., Smith H. Applied Regression Analysis. John Wiley & Sons, Inc., New York 1966; 67–69
- Paiva T. B., Miyamoto M. E., Paiva A. C.M. Irreversible inhibition of angiotensin II activity on the rat uterus by an alkylating angiotensin derivative. Pharmacology 1974; 12: 186–191
- Chevillotte E., Denynck M. A., Fyhrquist F., Meyer P., Rouzaire-Dubois B., Woral M. Angiotensin-induced variations of receptors in rat uterine membranes. Clin. Sci. Mol. Med. 1975; 48: 23s–26s
- Capponi A. M., Catt K. J. Angiotensin II receptors in adrenal cortex and uterus. J. Biol. Chem. 1979; 254: 5120–5127
- Pliška V., Marbach P. Some biological activities of an “irreversible” antagonist of neurohypophyseal hormones, deamino-[Phe(4-BrCHCONH)]-oxytocin, and its isosteric analogue, deamino-[Phe(4-BrCHCONH)]-oxytocin. Eur. J. Pharmacol. 1978; 49: 213–222
- Pliška V., Marbach P., Vašák J., Rudinger J. [2- -Iodotyrosine]-oxytocin and 2-[-methyltyrosine]-oxytocin: Basic pharmacology and comments on their potential use in binding studies. Experientia 1977; 33: 367–369
- Crankshaw D. J., Romaniuk E., Branda L. A. Identification and characterization of receptors for oxytocin in the myometrium of the pregnant ewe. Gynecol. Obstet. Invest. 1982; 14: 202–213
- Crankshaw D. J., Branda L. A., Matlib M. A., Daniel E. E. Localization of the oxytocin receptor in the plasma membrane of rat myometrium. Eur. J. Biochem. 1978; 86: 481–486
- Fuchs A.-R., Fuchs F., Husskin P., Soloff M. S., Fernström M. J. Oxytocin receptors and human parturition: A dual role for oxytocin in the initiation of labor. Science 1982; 215: 1396–1398
- Soloff M. S. Hormone-Receptor Interactions - Molecular Aspects, G. S. Levey. Marcel Dekker, Inc., New York 1976; 129–151
- Müller-Lhotsky A., Heiniger J., Pliška V. Oxytocin receptors on sheep myometrium cells: low affinity binding. 1984, Experientia in press.